SPEVIGO
LIVE

Serial Number

97278135

Owner

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Attorney

Max Moskowitz

First Use Date

Sep 1, 2022

Filing Date

Feb 22, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SPEVIGO Trademark

Serial Number: 97278135 • Registration: 7197428

SPEVIGO is a trademark filed by BOEHRINGER INGELHEIM INTERNATIONAL GMBH on February 22, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

BOEHRINGER INGELHEIM INTERNATIONAL GMBH (1,315 trademarks)

binger strasse 173
D-55216 INGELHEIM AM RHEIN , DE

Entity Type: 03

Trademark Details

Filing Date

February 22, 2022

Registration Date

October 17, 2023

First Use Anywhere

September 1, 2022

First Use in Commerce

September 1, 2022

Published for Opposition

December 27, 2022

Goods & Services

pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; Pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; Pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 17, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 17, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 9, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 8, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 2, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 2, 2023 AITU
USE AMENDMENT FILED
Jul 14, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 14, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 21, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 27, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 27, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 7, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 21, 2022 CNSA
ASSIGNED TO EXAMINER
Nov 19, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 28, 2022 NWOS
NEW APPLICATION ENTERED
Feb 25, 2022 NWAP